April 21, 2017 / 6:03 AM / 4 months ago

BRIEF-Vernalis Plc issues a complete response letter on CCP-07 NDA

April 21 (Reuters) - Vernalis Plc

* Vernalis Plc: FDA issues a complete response letter on CCP-07 NDA

* CRL did not raise any concerns with formulation or pharmacokinetic profile of CCP-07

* CRL did identify outstanding items that need to be addressed prior to resubmission and approval of NDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below